Skip to main content

Umbrella menu

  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Latest Articles
    • Issue Archive
    • Editorials
    • Research Highlights
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • EDITORIAL BOARD
  • BLOG
  • ABOUT
    • Overview
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

User menu

  • My alerts

Search

  • Advanced search
eNeuro
  • My alerts

eNeuro

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Latest Articles
    • Issue Archive
    • Editorials
    • Research Highlights
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • EDITORIAL BOARD
  • BLOG
  • ABOUT
    • Overview
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
PreviousNext
Research ArticleResearch Article: New Research, Development

Erythropoietin Stimulates GABAergic Maturation in the Mouse Hippocampus

Kasifa Khalid, Julia Frei, Mostafa A. Aboouf, Christina Koester-Hegmann, Max Gassmann, Jean-Marc Fritschy and Edith M. Schneider Gasser
eNeuro 25 January 2021, 8 (1) ENEURO.0006-21.2021; DOI: https://doi.org/10.1523/ENEURO.0006-21.2021
Kasifa Khalid
1Institute of Pharmacology and Toxicology, Neuroprotection Group, University of Zurich, Zurich 8057, Switzerland
3Neuroscience Centre Zurich, University of Zurich and Eidgenössische Technische Hochschule Zurich, Zurich 8057, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Frei
1Institute of Pharmacology and Toxicology, Neuroprotection Group, University of Zurich, Zurich 8057, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mostafa A. Aboouf
2Institute of Veterinary Physiology, Vetsuisse Faculty, and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich 8057, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Koester-Hegmann
1Institute of Pharmacology and Toxicology, Neuroprotection Group, University of Zurich, Zurich 8057, Switzerland
2Institute of Veterinary Physiology, Vetsuisse Faculty, and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich 8057, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Max Gassmann
2Institute of Veterinary Physiology, Vetsuisse Faculty, and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich 8057, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Marc Fritschy
1Institute of Pharmacology and Toxicology, Neuroprotection Group, University of Zurich, Zurich 8057, Switzerland
3Neuroscience Centre Zurich, University of Zurich and Eidgenössische Technische Hochschule Zurich, Zurich 8057, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edith M. Schneider Gasser
1Institute of Pharmacology and Toxicology, Neuroprotection Group, University of Zurich, Zurich 8057, Switzerland
2Institute of Veterinary Physiology, Vetsuisse Faculty, and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich 8057, Switzerland
3Neuroscience Centre Zurich, University of Zurich and Eidgenössische Technische Hochschule Zurich, Zurich 8057, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edith M. Schneider Gasser
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Increased number of GABA-immunoreactive neurons in the hippocampus from Tg21 mice. A, Representative images of double immunofluorescence staining against GABA (green) and NeuN (magenta) for CA3 and CA1 areas of WT and Tg21 mice at P21. so: stratum oriens, sp: stratum pyramidale, sr: stratum radiatum. B, Unbiased quantification of NeuN+ (upper graph) and GABA+ (middle graph) cells in total CA3 and CA1 area of WT and Tg21 mice, showing age-specific differences between genotypes. Ratio of GABA+/NeuN+ cells (lower graph) in WT and Tg21 mice, shows a significant increase of GABA+ cells at P14. Data are given as mean ± SD of total neuronal numbers in the CA1 and CA3 area of the hippocampus; N = 6 animals per age and genotype. Two-way ANOVA test, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Scale bar: 50 μm. C, Representative images of PV+, SST+, and NPY+ immunoperoxidase staining in hippocampus of WT and Tg21 mice at P14 illustrate the stronger immunoreactivity in PV, SST, and NPY in Tg21 mice. DG: dentate gyrus. D, Unbiased quantification of the total cell numbers in CA3 and CA1 areas, revealing increased numbers of PV+ cell in CA3, increased number of SST+ cells in CA1, and increased number of NPY+ cells in CA3 and CA1 in Tg21 mice. Data are given as mean ± SD, N = 6 animals per genotype for PV and NPY and N = 4 animals per genotype for SST staining. Multiple t test; *p < 0.05, **p < 0.01. Scale bar: 200 μm.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Early onset of PV expression in the hippocampus from Tg21 mice. A, Representative images of PV immunoperoxidase staining in CA3 and CA1 areas of WT and Tg21 mice at P7, P11, and P21. Note the earlier appearance of PV+ cells in the CA3 area (P7). Scale bar: 50 μm. B, Unbiased quantification of the total PV+ cell numbers at each represented postnatal time point for WT and Tg21 mice. Multiple t test; *p < 0.05, **p < 0.01. C, Significant differences in PV+ cell numbers between genotypes occur in CA3 area at P7, P11, and P14. Grofit interference analysis, *p < 0.05, **p < 0.01. D, Significant difference in PV+ intensity is to observe in the CA3 area at postnatal ages: 7, 11, 14, and 21; and in the CA1 area at postnatal ages: 14 and 21. Data are given as scatter dot plots and mean ± SD, N = 6 animals per genotype. Two-way ANOVA test; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. E, Representative images of cleaved caspase-3 (green) and DAPI (blue) staining in CA1 areas of WT and Tg21 mice at P7. Scale bar: 50 μm. F, Cleaved caspase-3 quantification in WT and Tg21in CA3 and CA1 area at P7 and P11. A significant reduction in apoptosis at P7 is observed in Tg21 mice. Two-way ANOVA; *p < 0.05.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    EPO influences PNN formation around PV+ cells in the hippocampal CA1 and CA3 areas. A, Representative images of double labeling for PV immunoreactivity (magenta) and WFA fluorescence that identify PNNs (green) and merged images in CA3 and CA1 areas at P11. Scale bar: 100 μm. B, Quantification of PV+ cells surrounded by PNN (WFA+) in CA3 and CA1 across postnatal ages. No increase in WFA+ cells nor change in the onset is observed between genotypes. C, WFA intensity in CA3 and CA1 across postnatal ages. WFA fluorescence intensity is stronger in Tg21 mice CA3 area at P11 and in CA1 area at P11 and P14. D, PV intensity in WFA+ cells in CA3 and CA1 area across postnatal ages. PV intensity is stronger in CA3 and CA1 areas at P11 in Tg21 mice. E, Correlation analysis of PV and WFA fluorescence intensity in WT and Tg21 mice CA1 area at P11. r: Pearson correlation. F, PV+ cells soma size at P11. PV+ cells covered by WFA have larger cell somas in CA3 and CA1 area from WT and Tg21 mice. WFA+/PV+ cells are larger in Tg21 mice CA1 area. G, PV immunofluorescence intensity at P11. PV intensity is stronger in WFA+ cells, and the intensity is even higher in Tg21 mice in CA3 and CA1 areas. Graphs (B–F) show scatter dot plots and mean bars ± SD, N = 6 animals per age and genotype. Two-way ANOVA; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Increased GABAAR cluster density in CA1 pyramidal cells of Tg21 mice at P14. A, Representative images of immunofluorescence staining against VGAT: vesicular GABA transporter (blue), gephyrin (green), and γ2-GABAAR subunit (red) in WT and Tg21 mice. B, Quantification of presynaptic (VGAT) terminals in WT and Tg21 mice showing increased terminal size (cumulative plot) in Tg21 mice. C, Quantification of postsynaptic clusters of gephyrin showing increased cluster number (bar graph) and size (cumulative plot). D, Quantification of γ2-GABAAR subunits in WT and Tg21 mice showing increased density (bar graph) in Tg21 mice. Density of postsynaptic (triple labeled) clusters in WT and Tg21 mice at P14 (E), P21(F), and P60 (G). Bar graphs show mean ± SD, data points represent individual mice, N = 5 animals per age and genotype, Student’s t test (B–J). Cumulative frequency plots show total number of quantified clusters in WT and Tg21 animals; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Scale bar: 10 μm.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Enhancement of GABAergic synaptic transmission in CA1 area of Tg21 mice at P13–P15. A, Representative raw and averaged mean traces of the mIPSCs in WT and Tg21 mice at P13–P15. B–E, Cumulative frequency distribution plots and data points graphs at P13–P15 of (B) IEIs and frequency, (C) amplitude, (D) rise-time constant, and (E) decay-time constant of the mIPSCs from WT (black bars) and Tg21 (red bars). An increase in frequency, amplitude, rise time, and decay time is observed in Tg21mice at P13–P15. F, Representative raw and averaged mean traces of the mIPSCs for WT and Tg21 mice at P19–P22. G–J, Cumulative frequency distribution plots at P19–P22 of (G) IEIs and frequency, (H) amplitude, (I) rise-time constant, and (J) decay-time constant. No differences are observed in Tg21 mice at P19–P22. Graphs show mean ± SD, data points represent individual mice, N = 9 animals per genotype (P13–P15) and N = 8 animals (P19–P22), Student’s t test. Cumulative frequency plots show total number of events in WT and Tg21 animals, KS tests; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    EPORs expression in the CA1 area is restricted to principal cells. Representative images of fISH for mRNA EPORs (green dots) colabeled with DAPI (gray) in WT and Tg21 mice at P7, P11, and P21 in (A) stratum pyramidale (SP) and (C) stratum radiatum (SR). Negative control (P7): fluorophore; positive control (P7): housekeeping gene. Scale bar: 10 μm. Quantification of EPOR mRNA dots in CA1 SP (B) and CA1 SR (D) at different postnatal ages, showing its selective presence in SP throughout postnatal development. More EPOR mRNA dots are quantified at P7 in Tg21 mice. Data are given as mean with individual values ± SD, N = 6 animals per genotype and age. Two-way ANOVA test; CA1 SP, ***p < 0.001.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Constitutive deletion of EPORs from Gad65 cells has no impact on the GABAergic system. A, Representative images of fISH for EPORs in GAD65-cre+/+, EPORfx/fx mice and GAD65-creTg/+, EPORfx/fx (GAD65: Glutamat decarboxylase isoform 65) mice at P11 in CA1 stratum pyramidale area. B, Quantification of EPOR mRNA dots in CA1 area, showing no effect of the targeted mutation. C, Representative images of PV immunoperoxidase staining in GAD65-cre+/+, EPORfx/fx mice and GAD65-creTg/+, EPORfx/fx mice at P11 showing no change in PV immunostaining. D, Unbiased quantification of PV+ cell numbers in CA1 area shows no alteration in cell numbers on deletion of EPOR in interneurons. Data are given as mean ± SD, N = 3 animals and 3 hippocampi per genotype for fISH and N = 6 animals per genotype for PV stereology. Two-way ANOVA test. Scale bars: 10 μm (A) and 200 μm (C).

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Increased density of glutamatergic terminals on PV+ interneurons of Tg21 mice at P14. A, Representative images of double immunofluorescence staining for VGluT1-2 (magenta) and PV (blue) in hippocampus of WT and Tg21 mice. B, Quantification of VGluT1&2+ puncta in PV+ cells, showing higher numbers in Tg21 mice. C, D, No change in puncta size between genotypes was observed. Bar graphs are given as mean ± SD, N = 4 animals per genotype and 2 hippocampi per animal. 10 to 15 PV+ cells were quantified per hippocampi and area. Student’s t test, **p, 0.01, KS tests n.s. Scale bar: 10 mm.

Tables

  • Figures
    • View popup
    Table 1

    Primary antibodies used for immunohistochemistry

    TargetHost speciesDilutionCatalog #Company/originReferences
    γ-aminobutyric acid (GABA)Rabbit1:1000A-2052SigmaDzyubenko et al. (2017)
    Neuronal nuclei (NeuN)Mouse monoclonal1:1000MAB377MerckMullen et al. (1992)
    PVRabbit1:5000PV-28SWantVaghi et al. (2014)
    NPYRabbit1:1000T-4069Peninsula Lab.Mackay al. (2019)
    SSTRabbit1:500sc-13099Santa CruzYang et al. (2008)
    VGATMouse monoclonal1:2000131011Synaptic SystemsPan-Vazquez et al. (2020)
    GephyrinRabbit monoclonal1:1000147008Synaptic SystemsSchneider Gasser et al. (2006)
    GABAA R γ2Guinea pig1:2000N/AHome madeFritschy and Mohler (1995)
    vGluT1Guinea pig1:1000135304Synaptic SystemsWei et al. (2016)
    vGluT2Guinea pig1:3000AB2251MerckHolló et al. (2017)
    Cleaved caspase-3Rabbit1:2009661Cell SignalingTeoh et al. (2017)
Back to top

In this issue

eneuro: 8 (1)
eNeuro
Vol. 8, Issue 1
January/February 2021
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Erythropoietin Stimulates GABAergic Maturation in the Mouse Hippocampus
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Erythropoietin Stimulates GABAergic Maturation in the Mouse Hippocampus
Kasifa Khalid, Julia Frei, Mostafa A. Aboouf, Christina Koester-Hegmann, Max Gassmann, Jean-Marc Fritschy, Edith M. Schneider Gasser
eNeuro 25 January 2021, 8 (1) ENEURO.0006-21.2021; DOI: 10.1523/ENEURO.0006-21.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Erythropoietin Stimulates GABAergic Maturation in the Mouse Hippocampus
Kasifa Khalid, Julia Frei, Mostafa A. Aboouf, Christina Koester-Hegmann, Max Gassmann, Jean-Marc Fritschy, Edith M. Schneider Gasser
eNeuro 25 January 2021, 8 (1) ENEURO.0006-21.2021; DOI: 10.1523/ENEURO.0006-21.2021
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • EPOR
  • inhibition
  • interneurons
  • parvalbumin
  • perineuronal nets
  • postnatal development

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Using Cortical Neuron Markers to Target Cells in the Dorsal Cochlear Nucleus
  • Parvalbumin Interneurons Are Differentially Connected to Principal Cells in Inhibitory Feedback Microcircuits along the Dorsoventral Axis of the Medial Entorhinal Cortex
  • Traumatic brain injury broadly affects GABAergic signaling in dentate gyrus granule cells
Show more Research Article: New Research

Development

  • Auditory brainstem deficits from early treatment with a CSF1R inhibitor largely recover with microglial repopulation
  • Neuregulin-4 Is Required for Maintaining Soma Size of Pyramidal Neurons in the Motor Cortex
Show more Development

Subjects

  • Development
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2021 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.